Funder
Foundation for the National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference80 articles.
1. Antibiotic Resistance Threats in the United States (US Department of Health and Human Services, CDC, 2019).
2. Fenton, S., Stephenson, D. & Weder, C. Pseudomembranous colitis associated with antibiotic therapy—an emerging entity. Can. Med. Assoc. J. 111, 1110–1111 (1974). 1114.
3. Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L. & Onderdonk, A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298, 531–534 (1978).
4. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014).
5. Abt, M. C., McKenney, P. T. & Pamer, E. G. Clostridium difficile colitis: pathogenesis and host defence. Nat. Rev. Microbiol. 14, 609–620 (2016).